About Edwards Lifesciences and Edwards Lifesciences Foundation

Edwards Lifesciences, based in Irvine, Califorina, is the global leader in patientfocused medical innovations for structural heart disease, as well as critical care and surgical monitoring. Driven by a passion to help patients, the company collaborates with the world's leading clinicians and researchers to address unmet healthcare needs, improve patient outcomes and enhance lives.

In 2004, the company established what is now Edwards Lifesciences Foundation. The foundation focuses on supporting underserved structural heart and critical care patients, as well as strengthening the communities in which Edwards employees live and work. Since its inception, the foundation has gifted more than $100 million to non-profit organizations. Additional information can be found at Edwards.comand EveryHeartbeatMatters.org.

Available Products:

Edwards donates surgical structural heart and critical care technologies to MAP. There are no quantity request limits for products available periodically. MAP will manage the periodically available product inventory to support as many humanitarian programs as possible.

Eligibility to receive donated products will be determined based on the completed eligibility forms. Continued eligibility will be dependent upon reports received and adherence to the stated guidelines and signed agreements. MAP policy does not allow for transport of medical products to any U.S.- embargoed country, or country’s subject to economic sanctions, e.g. Cuba, Syria, Iran and North Korea, without the requesting physician providing proof of having obtained the required licensing from the appropriate departments of the U.S. government. Additionally, Edwards donated products are not available for humanitarian programs serving China.

MAP will assess a service fee of $250 per shipment, however, Edwards Lifesciences Foundation grants will be used to pay for the costs of shipments from MAP to partners’ U.S. locations. Exceptions can be requested for Edwards Foundation to pay for costs of shipments to locations outside the U.S. Please complete the following documents and submit them to MAP International Customer Service. For your courtesy, we have provided a downloadable version of the Eligibility Packet and Practitioner's Agreement for you to follow as you submit your response below.

Below you will also find instructions regarding reporting adverse events or product complaints related to Edwards products.

Instructions to report adverse events

Eligibility:

As part of its Every Heartbeat Matters (EHM) charitable initiative, Edwards Lifesciences donates surgical heart valve and critical care technologies to MAP International to support EHM humanitarian work treating underserved structural heart and critical care patients outside the U.S. (Note: donated products are not available for use in the U.S.)

A licensed physician's signature and confirmation of physician’s hospital privileges to perform treatment with requested donated technologies are required to receive donated medical products so MAP can validate clinical expertise. This physician must attest and agree to program requirements including the following:

1. Physician is trained to use requested products

2. Read, sign, and adhere to commitments of the program’s MOU

3. Promise to not sell or exchange donated products for money or services

4. All medical treatment provided with donated products will be performed as a charitable act and no entity will seek payment or reimbursement for treatment involving donated product. If you have any questions about this requirement, please reach out to MAP International prior to applying to the program.

5. All received donated product will either be used and registered with Edwards or disposed of in an appropriate manner

6. Read and understand instructions for reporting adverse events or product complaints to Edwards related to donated product

7. Donated products may not be used to treat government officials or their family, hospital employees or their family, requestor’s employees or their family, or non-profit organization's employees or their family

Products available for humanitarian medical programs outside the U.S. include surgical aortic and mitral replacement heart valves, surgical mitral and tricuspid repair rings, hemodynamic monitoring systems and related critical care sensors.

Global Impact of 2022

At MAP International, we believe that everyone deserves access to quality healthcare, no matter where they live. That’s why we’re committed to providing life-changing patient treatments to people in need around the world.

Our efforts have enabled us to provide critical medicines and health supplies to millions of people in 86 countries around the world. We’re also pleased to report that we increased our medicine delivery by $119 million from the previous year, totaling $745,372,921. Additionally, we provided $37,549,164 in disaster relief – a $24 million increase from 2021. Our mission is simple yet impactful: to provide essential medicines and health supplies to those in need so they can live life to the fullest.

In the fiscal year 2022 alone, we delivered over 16 million prenatal vitamins to 49 countries to support maternal and fetal health. We also provided over 119,000 oral rehydration salts, totaling nearly 3 million sachets, to 45 countries to help prevent dehydration. Additionally, we administered over 1.8 million deworming medications to patients in 15 countries and provided over 800,000 antibiotics to individuals in 57 countries. Through our Bringing Children Health (BCH) Program, we were able to reach over 324,000 children – an increase of over 243,000 from the previous year. By targeting our efforts where they’re needed most, we can make a real impact and improve the health and wellbeing of children around the world.

Thanks to our dedicated team and generous supporters, we’re able to make a real difference in the lives of those who need it most. Join us in our mission to create a healthier, more equitable world today.

Read our Annual Report

Edwards Lifesciences philanthropic initiative, Every Heartbeat Matters, focuses on impacting the lives of underserved patients around the world. As of 2020, the Every Heartbeat Matters community has impacted the global burden of heart valve disease by educating, screening and treating over 1.7 million underserved people. Now Every Heartbeat Matters is committed to improving the lives 2.5 million additional underserved structural heart and critical care patients by the end of 2025.

Edwards partners with MAP International to bring its donated medical innovations to underserved patients around the world. Every Heartbeat Matters surgical and critical care products can be ordered through MAP International’s Online Ordering Portal.

Through the MAP International online ordering portal, Edwards offers EHM partners donated technologies to perform humanitarian treatment for underserved structural heart and critical care patients outside the U.S.

Become an EHM partner and view products available for humanitarian care.

Apply to access product
View product listing

In partnership with Edwards Lifesciences: Every Heartbeat Matters, MAP also offers patient care packages.

Terms and conditions may apply.
Every Heartbeat Matter Care Package >
Eligibility
Available Products
About Edwards Lifesciences and Edwards Lifesciences Foundation

Additional information can be found at Edwards.com and EveryHeartbeatMatters.org.

Medical Mission Feedback Form: Share Your Story!

All individuals who receive Every Heartbeat Matters product donations are required to submit a completed feedback form when they return from their trip.

We recognize that some medical outreach initiatives require a range of medicine and health supplies that is broader than what is offered through the Every Heartbeat Matters program. If you are looking for a wider range of products, visit the Short-Term Missions page administered by MAP International.

See additional health products

Additional information about MAP International can be found at MAP.org